ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,791 | -56.9% | 24,516 | -39.4% | 0.01% | -60.0% |
| Q2 2023 | $1,141,320 | +187.4% | 40,458 | +75.2% | 0.03% | +172.7% |
| Q1 2023 | $397,096 | +93.7% | 23,087 | +216.3% | 0.01% | +22.2% |
| Q2 2022 | $205,000 | -25.7% | 7,298 | +22.1% | 0.01% | -30.8% |
| Q1 2022 | $276,000 | -78.2% | 5,975 | -60.3% | 0.01% | -83.3% |
| Q4 2021 | $1,266,000 | +298.1% | 15,061 | +152.3% | 0.08% | +188.9% |
| Q2 2021 | $318,000 | -9.9% | 5,969 | -12.2% | 0.03% | -27.0% |
| Q4 2020 | $353,000 | – | 6,798 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |